Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 165

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Klf4 Is a Transcriptional Regulator of Genes Critical for EMT, Including Jnk1 (Mapk8)

Open access
Tiwari, Neha, Meyer-Schaller, Nathalie, Arnold, Phil, Antoniadis, Helena, Pachkov, Mikhail, van Nimwegen, Erik, Christofori, Gerhard · 2013 · PLoS ONE

Abstract

We have identified the zinc-finger transcription factor Kruppel-like factor 4 (Klf4) among the transcription factors that are significantly downregulated in their expression during epithelial-mesenchymal transition (EMT) in mammary epithelial cells and in breast cancer cells. Loss and gain of function experiments demonstrate that the down-regulation of Klf4 expression is required for the induction of EMT in vitro and for metastasis in vivo. In addition, reduced Klf4 expression correlates with shorter disease-free survival of subsets of breast cancer patients. Yet, reduced expression of Klf4 also induces apoptosis in cells undergoing TGFβ-induced EMT. Chromatin immunoprecipitation/deep-sequencing in combination with gene expression profiling reveals direct Klf4 target genes, including E-cadherin (Cdh1), N-cadherin (Cdh2), vimentin (Vim), β-catenin (Ctnnb1), VEGF-A (Vegfa), endothelin-1 (Edn1) and Jnk1 (Mapk8). Thereby, Klf4 acts as a transcriptional activator of epithelial genes and as a repressor of mesenchymal genes. Specifically, increased expression of Jnk1 (Mapk8) upon down-regulation of its transcriptional repressor Klf4 is required for EMT cell migration and for the induction of apoptosis. The data demonstrate a central role of Klf4 in the maintenance of epithelial cell differentiation and the prevention of EMT and metastasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0057329

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 47

  1. JP Thiery, 2006, Complex networks orchestrate epithelial-mesenchymal transitions, Nat Rev Mol Cell Biol, 7, 131, 10.1038/nrm1835 · DOI · Paper page
  2. G Christofori, 2006, New signals from the invasive front, Nature, 441, 444, 10.1038/nature04872 · DOI · Paper page
  3. T Brabletz, 2005, Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression, Nat Rev Cancer, 5, 744, 10.1038/nrc1694 · DOI · Paper page
  4. S Grunert, 2003, Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis, Nat Rev Mol Cell Biol, 4, 657, 10.1038/nrm1175 · DOI · Paper page
  5. MA Huber, 2005, Molecular requirements for epithelial-mesenchymal transition during tumor progression, Curr Opin Cell Biol, 17, 548, 10.1016/j.ceb.2005.08.001 · DOI · Paper page
  6. JP Thiery, 2009, Epithelial-mesenchymal transitions in development and disease, Cell, 139, 871, 10.1016/j.cell.2009.11.007 · DOI · Paper page
  7. M Yilmaz, 2011, Transcription factor Dlx2 protects from TGFbeta-induced cell-cycle arrest and apoptosis, EMBO J, 30, 4489, 10.1038/emboj.2011.319 · DOI
  8. F Lehembre, 2008, NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin, EMBO J, 27, 2603, 10.1038/emboj.2008.178 · DOI · Paper page
  9. JM Shields, 1996, Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest, J Biol Chem, 271, 20009, 10.1074/jbc.271.33.20009 · DOI · Paper page
  10. DT Dang, 2000, Decreased expression of the gut-enriched Kruppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients, FEBS Lett, 476, 203, 10.1016/S0014-5793(00)01727-0 · DOI
  11. JP Katz, 2005, Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach, Gastroenterology, 128, 935, 10.1053/j.gastro.2005.02.022 · DOI · Paper page
  12. S Ohnishi, 2003, Downregulation and growth inhibitory effect of epithelial-type Kruppel-like transcription factor KLF4, but not KLF5, in bladder cancer, Biochem Biophys Res Commun, 308, 251, 10.1016/S0006-291X(03)01356-1 · doi:10.1016/s0006-291x(03)01356-1
  13. JL Shie, 2000, Role of gut-enriched Kruppel-like factor in colonic cell growth and differentiation, Am J Physiol Gastrointest Liver Physiol, 279, G806, 10.1152/ajpgi.2000.279.4.G806 · doi:10.1152/ajpgi.2000.279.4.g806
  14. H Ton-That, 1997, Expression of the gut-enriched Kruppel-like factor gene during development and intestinal tumorigenesis, FEBS Lett, 419, 239, 10.1016/S0014-5793(97)01465-8 · DOI
  15. D Wei, 2005, Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression, Cancer Res, 65, 2746, 10.1158/0008-5472.CAN-04-3619 · DOI · Paper page
  16. W Zhao, 2004, Identification of Kruppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer, Oncogene, 23, 395, 10.1038/sj.onc.1207067 · DOI · Paper page
  17. KW Foster, 2000, Increase of GKLF messenger RNA and protein expression during progression of breast cancer, Cancer Res, 60, 6488
  18. KW Foster, 2005, Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia, Oncogene, 24, 1491, 10.1038/sj.onc.1208307 · DOI · Paper page
  19. KW Foster, 1999, Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF, Cell Growth Diff, 10, 423
  20. K Akaogi, 2009, KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERalpha, Oncogene, 28, 2894, 10.1038/onc.2009.151 · DOI
  21. BD Rowland, 2005, The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene, Nat Cell Biol, 7, 1074, 10.1038/ncb1314 · DOI · Paper page
  22. K Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
  23. M Wernig, 2007, In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state, Nature, 448, 318, 10.1038/nature05944 · DOI · Paper page
  24. JA Segre, 1999, Klf4 is a transcription factor required for establishing the barrier function of the skin, Nat Genet, 22, 356, 10.1038/11926 · DOI · Paper page
  25. JL Yori, 2010, Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression, J Biol Chem, 285, 16854, 10.1074/jbc.M110.114546 · DOI · Paper page
  26. L Waldmeier, 2012, Py2T Murine Breast Cancer Cells, a Versatile Model of TGFbeta-Induced EMT In Vitro and In Vivo, PloS One, 7, e48651, 10.1371/journal.pone.0048651 · DOI
  27. M Deckers, 2006, The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells, Cancer Res, 66, 2202, 10.1158/0008-5472.CAN-05-3560 · DOI · Paper page
  28. J Bergh, 1995, Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy, Nat Med, 1, 1029, 10.1038/nm1095-1029 · DOI · Paper page
  29. AV Ivshina, 2006, Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer, Cancer Res, 66, 10292, 10.1158/0008-5472.CAN-05-4414 · DOI · Paper page
  30. C Desmedt, 2007, Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series, Clin Cancer Res, 13, 3207, 10.1158/1078-0432.CCR-06-2765 · DOI · Paper page
  31. X Chen, 2001, Kruppel-like factor 4 (gut-enriched Kruppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle, J Biol Chem, 276, 30423, 10.1074/jbc.M101194200 · DOI · Paper page
  32. F Yu, 2011, Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion, Oncogene, 30, 2161, 10.1038/onc.2010.591 · DOI · Paper page
  33. JL Yori, 2011, Kruppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer, Neoplasia, 13, 601, 10.1593/neo.11260 · DOI
  34. R Li, 2010, A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts, Cell Stem Cell, 7, 51, 10.1016/j.stem.2010.04.014 · DOI · Paper page
  35. B Derijard, 1994, JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain, Cell, 76, 1025, 10.1016/0092-8674(94)90380-8 · DOI · Paper page
  36. JF Santibanez, 2006, JNK mediates TGF-beta1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes, FEBS Lett, 580, 5385, 10.1016/j.febslet.2006.09.003 · DOI
  37. JF Alcorn, 2008, Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-beta1, J Cell Sci, 121, 1036, 10.1242/jcs.019455 · DOI
  38. JL van der Velden, 2010, c-Jun N-Terminal Kinase 1 Promotes TGF-{beta}1-induced Epithelial to Mesenchymal Transition via Control of Linker Phosphorylation and Transcriptional Activity of Smad3, Am J Resp Cell Mol Biol, 47, 306
  39. C Huang, 2003, JNK phosphorylates paxillin and regulates cell migration, Nature, 424, 219, 10.1038/nature01745 · DOI · Paper page
  40. C Cellurale, 2012, Role of JNK in mammary gland development and breast cancer, Cancer Res, 72, 472, 10.1158/0008-5472.CAN-11-1628 · DOI
  41. C Cellurale, 2010, Role of JNK in a Trp53-dependent mouse model of breast cancer, PloS One, 5, e12469, 10.1371/journal.pone.0012469 · DOI
  42. P Chen, 2010, Jnk2 effects on tumor development, genetic instability and replicative stress in an oncogene-driven mouse mammary tumor model, PloS One, 5, e10443, 10.1371/journal.pone.0010443 · DOI
  43. M Maeda, 2005, Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition, J Cell Sci, 118, 873, 10.1242/jcs.01634 · DOI · Paper page
  44. K Takahashi, 2007, Induction of pluripotent stem cells from fibroblast cultures, Nat Protocols, 2, 3081, 10.1038/nprot.2007.418 · DOI · Paper page
  45. CJ Strock, 2006, Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells, Cancer Res, 66, 7509, 10.1158/0008-5472.CAN-05-3048 · DOI · Paper page
  46. M Weber, 2007, Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome, Nat Genetics, 39, 457, 10.1038/ng1990 · DOI · Paper page
  47. VK Tiwari, 2012, A chromatin-modifying function of JNK during stem cell differentiation, Nat Genetics, 44, 94, 10.1038/ng.1036 · DOI

Cited by

See all 165

Metadata

Authors
Tiwari, N., Meyer-Schaller, N., Arnold, P., Antoniadis, H., Pachkov, M., van Nimwegen, E., & Christofori, G.
Venue
PLoS ONE
Published
2013-02-25
Volume
8
Issue
2
Pages
e57329
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2019723293
Cited by
165
References
2
FWCI
7.80
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Klf4 Is a Transcriptional Regulator of Genes Critical for EMT, Including Jnk1 (Mapk8). https://app.cochat.ai/papers/10.1371/journal.pone.0057329
The paper
Tiwari, N., Meyer-Schaller, N., Arnold, P., Antoniadis, H., Pachkov, M., van Nimwegen, E., & Christofori, G. (2013). Klf4 Is a Transcriptional Regulator of Genes Critical for EMT, Including Jnk1 (Mapk8). PLoS ONE. https://doi.org/10.1371/journal.pone.0057329

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.